Cancer Patient Navigation and Readiness
CPN Readiness
Effect of Cancer Patient Navigation Services on Health-Illness Transition Readiness Among Women With Newly Diagnosed Breast Cancer: A Quasi-Experimental Study
1 other identifier
interventional
64
1 country
1
Brief Summary
This study evaluated whether Cancer Patient Navigation (CPN) services could improve readiness for the transition from breast cancer diagnosis to treatment. The study involved 64 women newly diagnosed with stage I-IIIA breast cancer who experienced high psychological distress at a cancer referral hospital in Indonesia. Participants were assigned to either a navigation group or a standard care group without randomization. Women in the navigation group received a 30-day support program that included education about breast cancer, guidance on treatment preparation, assistance with care coordination, and emotional support. The program included three to four hospital-based sessions during scheduled visits, a patient education booklet, and online nutrition education. Women in the comparison group received standard care. Participants' readiness to manage changes related to their cancer diagnosis and prepare for treatment was assessed before and after the study using the Measurement of Transitions in Cancer Scale. The study aimed to determine whether women receiving navigation services experienced greater improvements in transition readiness than those receiving standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Jan 2026
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedFirst Submitted
Initial submission to the registry
October 17, 2026
CompletedFirst Posted
Study publicly available on registry
October 23, 2026
CompletedOctober 23, 2026
October 1, 2026
3 months
October 17, 2026
October 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Health-Illness Transition Readiness
Health-illness transition readiness was assessed using the Measurement of Transitions in Cancer Scale (MOT-CA). The primary outcome was the change in transition readiness scores from baseline to post-intervention, comparing women who received Cancer Patient Navigation services with those who received standard care. The assessment included the care transition and management of change domains.
Baseline and 30 days after baseline
Study Arms (2)
Cancer Patient Navigation Group
EXPERIMENTALParticipants in this group received a structured 30-day Cancer Patient Navigation program consisting of three to four hospital-based sessions during scheduled visits. The intervention included breast cancer education, clinical guidance, care coordination, psychosocial support, an educational booklet, and online nutrition education.
Standard Care Group
NO INTERVENTIONParticipants in this group received standard care provided by the hospital without the additional structured Cancer Patient Navigation intervention.
Interventions
The intervention consisted of a structured 30-day Cancer Patient Navigation program for women newly diagnosed with breast cancer. Participants received three to four hospital-based navigation sessions during scheduled clinical visits. The program provided education about breast cancer, guidance on treatment preparation, assistance with healthcare coordination, and psychosocial support. Additional resources included a patient education booklet and online nutrition education. The intervention aimed to support patients in understanding their diagnosis, addressing care-related needs, and preparing for the transition from diagnosis to treatment initiation.
Eligibility Criteria
You may not qualify if:
- Patients with a history of cancer other than breast cancer.
- Patients who are unwilling to participate as respondents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RSUP Dr. Sardjito
Yogyakarta, 55281, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agung Subakti Nuzulullail, BSN., RN., M.N.Sc.
Universitas Muhammadiyah Semarang
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
October 17, 2026
First Posted
October 23, 2026
Study Start
January 6, 2026
Primary Completion
March 30, 2026
Study Completion
March 30, 2026
Last Updated
October 23, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly to protect participant confidentiality and privacy. The dataset contains sensitive health-related information from women diagnosed with breast cancer. Access to individual-level data will remain restricted to the research team in accordance with applicable ethical and institutional requirements.